Ann: Japanese Patent Office to grant key patent for Progenza, page-19

wasa

Thanks for the kind words.

For what it's worth (and it may be worth very little), I'm thinking that a "short timeframe" could be any time within the next 6 months, given the company's persistent use of tantalising phrase sets such as:being in "advanced discussions with potential licensees of Progenza rights for disease specific indications in Japan" (24/5/17 announcement); and, now having positive clinical data to support "near term Progenza licensing opportunities in Japan"(22/5/17 announcement).

zeno9